학술논문
Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation
Document Type
Article
Author
Source
In Lung Cancer June 2023 180
Subject
Language
ISSN
0169-5002